- Home
- CPOP vs NRXP Comparison
CPOP vs NRXP Comparison
Compare CPOP & NRXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPOP
- NRXP
- Stock Information
- Founded
- CPOP 2007
- NRXP 2015
- Country
- CPOP China
- NRXP United States
- Employees
- CPOP N/A
- NRXP N/A
- Industry
- CPOP Services-Misc. Amusement & Recreation
- NRXP Biotechnology: Pharmaceutical Preparations
- Sector
- CPOP Consumer Discretionary
- NRXP Health Care
- Exchange
- CPOP Nasdaq
- NRXP Nasdaq
- Market Cap
- CPOP 68.0M
- NRXP 58.5M
- IPO Year
- CPOP 2021
- NRXP N/A
- Fundamental
- Price
- CPOP $0.70
- NRXP $3.14
- Analyst Decision
- CPOP
- NRXP Strong Buy
- Analyst Count
- CPOP 0
- NRXP 5
- Target Price
- CPOP N/A
- NRXP $31.40
- AVG Volume (30 Days)
- CPOP 218.6K
- NRXP 439.7K
- Earning Date
- CPOP 06-30-2025
- NRXP 11-13-2025
- Dividend Yield
- CPOP N/A
- NRXP N/A
- EPS Growth
- CPOP N/A
- NRXP N/A
- EPS
- CPOP N/A
- NRXP N/A
- Revenue
- CPOP $65,186,721.00
- NRXP N/A
- Revenue This Year
- CPOP N/A
- NRXP N/A
- Revenue Next Year
- CPOP N/A
- NRXP $395.09
- P/E Ratio
- CPOP N/A
- NRXP N/A
- Revenue Growth
- CPOP 108.29
- NRXP N/A
- 52 Week Low
- CPOP $0.46
- NRXP $1.12
- 52 Week High
- CPOP $2.61
- NRXP $6.01
- Technical
- Relative Strength Index (RSI)
- CPOP 36.85
- NRXP 50.20
- Support Level
- CPOP $0.70
- NRXP $3.05
- Resistance Level
- CPOP $0.80
- NRXP $3.29
- Average True Range (ATR)
- CPOP 0.06
- NRXP 0.25
- MACD
- CPOP -0.00
- NRXP -0.03
- Stochastic Oscillator
- CPOP 0.50
- NRXP 22.47
About CPOP Pop Culture Group Co. Ltd
Pop Culture Group Co Ltd hosts entertainment events, operates hip-hop-related online programs, and provides event planning and execution services and marketing services to corporate clients. It generates revenue from Event Hosting business by providing sponsorship packages to advertisers in exchange for sponsorship fees and by selling tickets for those concerts. The company has various operations services out of which Brand Promotion earns maximum revenue, following by Event Hosting, and Event Planning and Execution.
About NRXP NRX Pharmaceuticals Inc.
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.